Moschip to acquire 73% stake in Belagavi-based Vyvya Labs for Rs 245.49 crore – All about Belagavi & more related News Here

ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundaio (orfoglipron) to date, confirms its cardiovascular and overall safety profile as well as consistent improvements in key measures of cardiometabolic health – Eli Lilly

 & more related News Here

  1. Moschip to acquire 73% stake in Belagavi-based Vyvya Labs for Rs 245.49 croreAll about Belgaum
  2. The stock jumped 7% after the company acquired a 73% stake in Viavya Labs to boost semiconductor capabilities.business mind
  3. Moschip Technologies board approves acquisition of 73% stake in Vyavya Labsbusiness standard
  4. Multibagger semiconductor company approves acquisition worth Rs 245 crore; Share price increased by 4%Dalal Street Investment Journal
  5. MosChip shares rise 5% as board approves acquisition of 73% of Vyavya Labs for Rs 245 croremoneycontrol.com

Leave a Reply

Your email address will not be published. Required fields are marked *